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Lipopolysaccharide (LPS) is a critical virulence determinant in Pasteurella multocida and a major antigen
responsible for host protective immunity. In other mucosal pathogens, variation in LPS or lipooligosaccharide
structure typically occurs in the outer core oligosaccharide regions due to phase variation. P. multocida
elaborates a conserved oligosaccharide extension attached to two different, simultaneously expressed inner
core structures, one containing a single phosphorylated 3-deoxy-D-manno-octulosonic acid (Kdo) residue and
the other containing two Kdo residues. We demonstrate that two heptosyltransferases, HptA and HptB, add the
first heptose molecule to the Kdo1 residue and that each exclusively recognizes different acceptor molecules.
HptA is specific for the glycoform containing a single, phosphorylated Kdo residue (glycoform A), while HptB
is specific for the glycoform containing two Kdo residues (glycoform B). In addition, KdkA was identified as
a Kdo kinase, required for phosphorylation of the first Kdo molecule. Importantly, virulence data obtained
from infected chickens showed that while wild-type P. multocida expresses both LPS glycoforms in vivo,
bacterial mutants that produced only glycoform B were fully virulent, demonstrating for the first time that
expression of a single LPS form is sufficient for P. multocida survival in vivo. We conclude that the ability of
P. multocida to elaborate alternative inner core LPS structures is due to the simultaneous expression of two
different heptosyltransferases that add the first heptose residue to the nascent LPS molecule and to the
expression of both a bifunctional Kdo transferase and a Kdo kinase, which results in the initial assembly of
two inner core structures.
Pasteurella multocida is a gram-negative bacterial pathogen
that causes disease in a wide range of mammals and birds. P.
multocida is classified into serogroup A, B, D, E, or F based on
capsular composition and is further classified into 16 Hed-
dleston serotypes based on lipopolysaccharide (LPS) antigens.
The type of disease that each strain can cause correlates to
some degree with the type of capsule that is expressed, with
serogroup A and occasionally serogroup F strains associated
with fowl cholera outbreaks in birds, serogroup B and E strains
with bovine hemorrhagic septicemia, and toxigenic serogroup
D strains with atrophic rhinitis in pigs (5).
The expression of wild-type LPS is critical for the progres-
sion of fowl cholera (13). The structure of the LPS has been
determined for two serotype A:1 fowl cholera strains, VP161
and X73, and the genome-sequenced strain Pm70 (28–30). The
LPS expressed by P. multocida is similar to the LPS (often
designated lipooligosaccharide) expressed by other mucosal
pathogens, including species within the Neisseria and Hae-
mophilus genera that have mono- and oligosaccharide exten-
sions to the core structure but lack O-antigen polysaccharide
repeating units (9, 10, 22, 26, 30). The LPS structures ex-
pressed by the three P. multocida strains VP161, X73, and
Pm70 all share common regions but differ in their oligosaccha-
ride extension and side branches (28–30). Unusually, two LPS
glycoforms were expressed simultaneously by each strain,
which differed in the inner core region but retained the same
primary oligosaccharide extension (shown for VP161 in Fig. 1).
Semiquantitative analysis of the LPS expressed by each strain
showed that most glycoforms contained a single phosphory-
lated 3-deoxy-D-manno-octulosonic acid (Kdo) molecule that
was frequently substituted with a phosphoethanolamine
(PEtn) residue attached to the phosphate group (glycoform
A). Furthermore, this single Kdo glycoform was shown to have
a second glucose residue attached to the proximal heptose
(Fig. 1). The alternative inner core LPS structure contained
two unphosphorylated Kdo residues and lacked the second
glucose residue on the proximal heptose (glycoform B).
To determine which genes were involved in the biosynthesis
of each glycoform, we mutated two genes predicted to encode
heptosyltransferases that attach the first heptose residues to
Kdo and a gene predicted to encode a Kdo kinase required for
phosphorylation of the lipid A-Kdo1. The LPS structures ex-
pressed by these mutants were then elucidated, and the mu-
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tants were tested for their ability to cause disease in chickens,
allowing us to determine for the first time whether expression
of both glycoforms was required for virulence in the natural
host. Finally, we assessed the role of LPS structure in confer-
ring resistance to antimicrobial peptides which are predicted to
be important components of the chicken innate immune sys-
tem.
MATERIALS AND METHODS
Bacterial strains, plasmids, media, and growth conditions. The bacterial
strains and plasmids used in this study are listed in Table 1. Escherichia coli was
grown routinely in Luria-Bertani broth. P. multocida strains were grown in either
brain heart infusion (BHI) broth or nutrient broth (Oxoid, Basingstoke, U.K)
supplemented with yeast extract (3% wt/vol). Solid media were obtained by the
addition of 1.5% agar. When required, media were supplemented with specti-
nomycin (100 g/ml), streptomycin (50 g/ml), kanamycin (50 g/ml), or tetra-
cycline (2.5 g/ml for routine culturing or 8 g/ml for selection of P. multocida
transconjugants). For structural studies on LPS isolated from in vitro-grown P.
multocida, strains were grown on BHI plates with the appropriate antibiotics for
18 h at 37°C. For structural studies on LPS isolated from in vivo-grown P.
multocida, 103 CFU of strain X73 were injected into the breast muscles of
14-week Hy-Line Brown chickens and disease allowed to progress for 14 to 18 h.
When birds were showing clear clinical signs of fowl cholera, they were euthana-
tized by CO2 asphyxiation and 10 ml of blood was recovered by cardiac puncture.
Bacteria were purified from the blood as described previously (6). The cells were
killed by addition of phenol to 2%, and at 3 h after phenol addition, 1 g of
hyaluronidase (Roche Chemicals) was added and stirred for 1 h before cells were
harvested by using a Sharples continuous-flow centrifuge.
DNA manipulations. Restriction digests and ligations were performed accord-
ing to the manufacturers’ instructions using enzymes obtained from New En-
gland Biolabs (Beverley, MA) or Roche Diagnostics GmbH (Mannheim, Ger-
many). Plasmid DNA was prepared using alkaline lysis (4) and further purified
using QIAGEN columns (QIAGEN GmbH, Germany), while genomic DNA was
prepared using the cetyltrimethylammonium bromide method (2). PCR amplifi-
cation of DNA was performed using Taq DNA polymerase or the Expand high-
fidelity PCR system (Roche Diagnostics) and purified using the QIAGEN PCR
purification kit. The oligonucleotides used in this study are listed in Table 2. DNA
sequences were determined on an Applied Biosystems 3730S genetic analyzer and
analyzed with Sequencher version 3.1.1 (Gene Codes, Ann Arbor, MI).
Construction of P. multocida mutants. The three P. multocida strains Pm70,
X73, and VP161 have all been tested for amenability to mutant construction. To
date, insertional inactivation of target genes has routinely been successful only
for P. multocida strain VP161. For inactivation of each of the candidate glyco-
syltransferase genes in P. multocida strain VP161, we used a modification of the
previously described single-crossover insertional mutagenesis method which uti-
lizes the  pir-dependent plasmid pUA826 (7). Internal DNA fragments of kdkA
and hptB were amplified by PCR using the primers listed in Table 2, digested
with SalI, and ligated into SalI-digested pUA826. As single-crossover insertion of
pUA826 is likely to have polar effects on downstream genes, a different vector
was constructed for inactivation of the hptA gene, which bioinformatic analysis
suggested was cotranscribed with the gene PM1301. We modified pUA826 by
insertion of the P. multocida constitutive tpiA promoter between the pUA826
PstI sites located at bp 4789 and 5472 (generating pUA826tpi). Thus, single-
crossover insertion of derivatives of this plasmid would allow transcription of
downstream genes through initiation of transcription from the P. multocida tpiA
promoter located within the integrated plasmid. An internal fragment of hptA
was amplified by PCR using the oligonucleotides listed in Table 2, digested with
SalI, and ligated into SalI-digested pUA826tpi.
FIG. 1. LPS structure of P. multocida VP161 and predicted enzymes for selected biosynthetic steps. Two core types are observed, glycoforms
A and B. P. multocida X73 has identical LPS glycoform structures, with the exception of an additional PEtn moiety attached to each terminal
galactose residue. Glc, glucose; Hep, heptose; Gal, galactose; PCho, phosphocholine; Kdo, 3-deoxy-D-mannooctulosonate; P, phosphate.
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To generate each donor strain, each ligation mix was transformed into E. coli
SM10  pir cells and the transformants screened for recombinant pUA826 or
pUA826tpi. The correct recombinant plasmids were then mobilized into the
recipient P. multocida strain AL435 by conjugation. AL435 was used as the
recipient strain, as it is resistant to tetracycline (due to integration of Tn916 in
gene PM1417), expresses wild-type LPS, and is fully virulent (see Table 4). For
each mating, 1 ml of the recipient P. multocida strain AL435 and 1 ml of the
donor SM10  pir strain, harboring the appropriate recombinant plasmid, were
mixed and filtered through a 0.45-m filter which was then placed on a blood
agar plate and incubated at 30°C for 16 h. To recover the bacteria, filters were
vortexed in 3 ml of BHI. P. multocida transconjugants were selected by plating
the resuspended bacteria onto BHI containing tetracycline, streptomycin, and
spectinomycin. Single-crossover insertion of the recombinant plasmid into each
of the target genes was confirmed by PCR using flanking primers in combination
with a primer located within the vector sequence (Table 2).
In trans complementation of mutants. The complete open reading frame for
each gene to be complemented was amplified from P. multocida VP161 genomic
DNA using flanking oligonucleotides (Table 2). The amplified DNA fragments
were ligated into SalI- and BamHI-digested expression vector pAL99 (Table 1),
such that transcription of the gene would be driven by the constitutive P. mul-
tocida tpiA promoter. The nucleotide sequence of each of the recombinant
plasmids was determined to check fidelity of the cloned gene and then trans-
formed into the corresponding P. multocida mutant, generating the comple-
mented strains listed in Table 1. As a control, the vector pAL99 was transformed
separately into each mutant (Table 1).
Assessment of virulence. All animal experiments were approved by the rele-
vant Animal Ethics Committee. Groups of commercially obtained Hy-Line
Brown chickens, aged 12 weeks, were infected with approximately 103 CFU
(100 times the 50% infective dose) of P. multocida by injection into the pectoral
muscle, and the experiment was allowed to proceed for up to 39 h or until each
TABLE 1. Bacterial strains and plasmids used in this study
Strain or plasmid Relevant description Source or reference
Strains
P. multocida
X73 Serotype A:1 14
VP161 Serotype A:1, Vietnamese isolate from chickens 35
AL435 VP161 carrying a Tn916 insertion in gene PM1417, fully virulent This study
AL838 VP161 containing pAL99 This study
AL721 kdkA mutant of AL435 This study
AL839 AL721 containing pAL99 This study
AL840 AL721 containing pAL462 This study
AL690 hptB mutant of AL435 This study
AL844 AL690 containing pAL99 This study
AL845 AL690 containing pAL464 This study
AL836 Nonpolar hptA mutant of AL435 This study
AL846 AL836 containing pAL99 This study
AL847 AL836 containing pAL465 This study
E. coli
DH5 deoR endA1 gyrA96 hsdR17 (rK
 mK
) recA1 relA1 supE44 thi-1 (lacZYA-
argFV169) 80lacZM15 F
Bethesda Research
Laboratories
Sm10  pir Strain for propagation of pUA826 and its derivatives 23
Plasmids
pUA826 Mob, R6K replicon, Apr Strr Spcr, single-crossover insertional mutagenesis
vector
7
pUA826tpi As for pUA826 but containing 240-bp PstI fragment containing P. multocida
tpiA promoter region, nonpolar mutagenesis vector
This study
pAL99 P. multocida expression plasmid (Kanr), constitutive tpiA promoter upstream
of BamHI
13
pAL462 Complete kdkA gene cloned into pAL99 This study
pAL464 Complete hptB gene cloned into pAL99 This study
pAL465 Complete hptA gene cloned into pAL99 This study
TABLE 2. Oligonucleotides used in this study
Oligonucleotide Sequence Description
BAP3813 TTTGGAGTCGACAAGCGCGTATTCTTGGTT kdkA internal forward primer for mutagenesis
BAP3814 CACTTTGTCGACGTTCACCAAGCTGATGTG kdkA internal reverse primer for mutagenesis
BAP3914 AAAGGGATCCGTGGCCATTCGCTATCTCTG kdkA flanking forward primer for expression
BAP3915 TATGTGTCGACCTTATGCTTGATATCCCGC kdkA flanking reverse primer for expression
BAP3721 TATGTTGTCGACAAGTTGATTGGGTGGTCGAAG hptB internal forward primer for mutagenesis
BAP3722 TAAATGGTCGACTCCGGTGTCAACAGAAACAA hptB internal reverse primer for mutagenesis
BAP3745 TAATTGGGATCCAACCGGAATTGGTATTCG hptB flanking forward primer for expression
BAP3746 TCAAGAGTCGACTGCCGTATAGGCAGTTTCAA hptB flanking reverse primer for expression
BAP3719 CAAAACGTCGACGCAGTTACTGGCTGGTAT hptA internal forward primer for mutagenesis
BAP3720 TCAGTAGTCGACAACTTACATTGGGCGAGGA hptA internal reverse primer for mutagenesis
BAP3966 CACACAGGATCCATTGGACGAGATAATGATGCCG hptA flanking forward primer for expression
BAP3967 ATAACAGTCGACGGTTCATCATTGAACGTC hptA flanking reverse primer for expression
BAP2782 GCCCTACACAAATTGGGAGA pUA826 primer near SalI site
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bird was deemed incapable of survival, when birds were euthanatized in accor-
dance with animal ethics requirements. Blood samples for viable counts were
obtained from all birds with late clinical signs of infection and from all healthy
birds at 22 h postinfection. Postmortem samples of the site of injection were
taken from a representative sample of birds within each group and plated onto
BHI agar. Recovered bacteria were checked by PCR to confirm the identity of
the P. multocida strains present.
Competitive growth assays. Competitive growth assays were performed as
described previously (12) and used to quantify the relative growth rates of the P.
multocida strains in vivo. Mutants were identified as attenuated if the relative
competitive index (rCI) value was significantly less than 1.0 as determined by
statistical analysis using the one sided z test (P 	 0.05).
Antimicrobial peptide sensitivity assays. The chicken antimicrobial peptide
fowlicidin-1 (RVKRVWPLVIRTVIAGYNLYAIKKK) (36) was synthesized at
96% purity by Auspep (Parkville, Australia). For peptide sensitivity assays, wild-
type and mutant strains were grown to late exponential phase (optical density at
600 nm of 0.65), washed once and then diluted 1/10 in 10 mM phosphate (pH 

7.0), 10% BHI. Equal volumes of washed cells (100 l) and diluted peptide (0 to
4 g/ml in 10 mM phosphate [pH 7.0]) were mixed and incubated at 37°C for 1 h.
Numbers of surviving bacteria were determined by viable counts on BHI agar.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and silver stain-
ing. Proteinase K-treated whole-cell lysates were analyzed on a Bio-Rad mini-
protein gel apparatus, using sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis as described previously (18). LPS was then visualized by carbohydrate
silver staining (32).
Purification of LPS and LPS-OH. Cells were killed with 2% phenol, washed
four times with water, lyophilized and resuspended in 200 l of H2O containing
5 g of proteinase K, and incubated at 37°C for 5 h. The sample was heated to
70°C for 10 min, lyophilized, then dissolved in 200 l of ammonium acetate
buffer (20 mM, pH 7.4) containing 1 g of RNase and 2 g of DNase, incubated
at 37°C for 5 h, and then lyophilized. The crude LPS-containing samples were O
deacylated by dissolving in 200 l of anhydrous hydrazine and incubating with
stirring at 37°C for 1.5 h. Excess hydrazine was destroyed by addition of 5
volumes of ice-cold acetone to the chilled samples and repeated acetone
TABLE 3. Negative-ion CE-ES-MS data and proposed compositions of LPS-OH from the P. multocida VP161 wild-type and mutant strainsa
Strain (relevant
description)
Observed ions (m/z) Molecular ion (m/z) Relative
intensity Proposed composition(M  4H)4 (M  3H)3 (M  2H)2 Observed Calculated
VP161 (wild type) 992.4 2,980.2 2,977.6 0.1 2PCho, 3Hex, 4Hep, 2Kdo, lipid A-OH
999.6 3,001.8 2,999.5 0.3 2PCho, 4Hex, 4Hep, Kdo-P, lipid A-OH
1,033.0 3,101.0 3,100.7 0.3 2PCho, 3Hex, 4Hep, 2Kdo, lipid A-OH-PEtn
1,040.7 3,125.1 3,122.5 0.7 2PCho, 4Hex, 4Hep, Kdo-P, lipid A-OH-PEtn
1,081.7 3,247.7 3,245.6 1.0 2PCho, 4Hex, 4Hep, Kdo-P-PEtn,
lipid A-OH-PEtn
AL690 (hptB) 504.4 757.2 1,516.1 1,515.4 0.2 2Kdo, lipid A-OH-PEtn
780.3 1,040.4 3,124.7 3,122.5 0.2 2PCho, 4Hex, 4Hep, Kdo-P, lipid A-OH-PEtn
810.8 1,081.6 3,247.7 3,245.6 1.0 2PCho, 4Hex, 4Hep, Kdo-P-PEtn,
lipid A-OH-PEtn
AL844 (hptB  vector) 757.5 1,516.1 1,515.4 0.2 2Kdo, lipid A-OH-PEtn
1,040.8 3,124.7 3,122.5 0.3 2PCho, 4Hex, 4Hep, Kdo-P, lipid A-OH-PEtn
1,081.7 1,622.7 3,247.7 3,245.6 1.0 2PCho, 4Hex, 4Hep, Kdo-P-PEtn,
lipid A-OH-PEtn
AL845 (hptB,
complemented)
1,033.0 3,101.0 3,100.7 0.2 2PCho, 3Hex, 4Hep, 2Kdo, Lipid A-OH-PEtn
1,040.7 1,561.2 3,124.7 3,122.5 0.3 2PCho, 4Hex, 4Hep, Kdo-P, lipid A-OH-PEtn
1,081.8 1,622.8 3,247.7 3,245.6 1.0 2PCho, 4Hex, 4Hep, Kdo-P-PEtn,
lipid A-OH-PEtn
AL836 (hptA) 616.8 1,235.6 1,252.2 0.1 Kdo-P, lipid A-OH ( H2O)
451.6 678.4 1,358.8 1,375.2 0.5 Kdo-P-PEtn, lipid A-OH ( H2O)
1,033.4 1,549.9 3,102.6 3,100.6 1.0 2PCho, 3Hex, 4Hep, 2Kdo, lipid A-OH-PEtn
AL846 (hptA  vector) 616.8 1,235.6 1,252.2 0.1 Kdo-P, lipid A-OH ( H2O)
451.6 678.3 1,358.8 1,375.2 0.5 Kdo-P-PEtn, lipid A-OH ( H2O)
774.7 1,033.2 1,550.3 3,102.6 3,100.6 1.0 2PCho, 3Hex, 4Hep, 2Kdo, lipid A-OH-PEtn
AL847 (hptA,
complemented)
1,033.3 3,101.0 3,100.7 0.5 2PCho, 3Hex, 4Hep, 2Kdo, lipid A-OH-PEtn
1,040.7 1,561.2 3,124.7 3,122.5 1.0 2PCho, 4Hex, 4Hep, Kdo-P, lipid A-OH-PEtn
1,081.5 1,622.4 3,247.7 3,245.6 0.9 2PCho, 4Hex, 4Hep, Kdo-P-PEtn,
lipid A-OH-PEtn
AL721 (kdkA) 743.8 992.3 2,979.9 2,977.6 0.2 2PCho, 3Hex, 4Hep, 2Kdo, lipid A-OH
775.0 1,033.1 3,103.1 3,100.6 1.0 2PCho, 3Hex, 4Hep, 2Kdo, lipid A-OH-PEtn
825.5 1,101.2 3,306.3 3,303.6 0.2 2PCho, 3Hex, 4Hep, 2Kdo,
lipid A-OH-PEtn-P-PEtn
AL839 (kdkA  vector) 1,033.1 1,550.3 3,103.1 3,100.6 1.0 2PCho, 3Hex, 4Hep, 2Kdo, lipid A-OH-PEtn
AL840 (kdkA,
complemented)
1,033.3 3,101.0 3,100.7 0.2 2PCho, 3Hex, 4Hep, 2Kdo, lipid A-OH-PEtn
1,040.7 1,561.3 3,124.7 3,122.5 0.5 2PCho, 4Hex, 4Hep, Kdo-P, lipid A-OH-PEtn
1,081.7 1,622.8 3,247.7 3,245.6 1.0 2PCho, 4Hex, 4Hep, Kdo-P-PEtn,
lipid A-OH-PEtn
a Average mass units were used for calculation of molecular weights based on the following proposed composition: lipid A, 952.00; Hex, 162.15; Hep, 192.17; Kdo,
220.18; Kdo-P, 300.13; PEtn, 123.05; PCho, 165.05.
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washes. The O-deacylated LPS (LPS-OH) pellet was redissolved in H2O and
lyophilized.
MS. Capillary electrophoresis-electrospray ionization-mass spectrometry (CE-
ES-MS) was performed on a crystal model 310 CE instrument (AYI Unicam)
coupled to an API 3000 MS (Perkin-Elmer/Sciex) via a microionspray interface
(9). A sheath solution (isopropanol-methanol, 2:1) was delivered at a flow rate of
1 l/min to a low-dead-volume tee (250-m inner diameter; Chromatographic
Specialties). All aqueous solutions were filtered through a 0.45-m filter (Milli-
pore) before use.
RESULTS
Bioinformatic prediction of inner core LPS biosynthesis
genes. Putative LPS biosynthesis genes in P. multocida VP161
were identified based on their similarity to LPS transferases of
known function in other bacteria using both BLAST (1) and
the CAZY database of glycosyltransferases (8). Two candidate
genes, hptA (annotated on the Pm70 genome as opsX) and
hptB (PM1843), had been predicted to encode the 38.4- and
36.3-kDa heptosyltransferases required for the addition of the
first heptose residue to either the lipid A-Kdo1-Kdo2 or the
lipid A-Kdo2-P core structure (Fig. 1) (30). A conserved do-
main search (21) showed that both had high levels of identity
to heptosyltransferases belonging to pfam01075, the glycosyl-
transferase family 9, and COG0859, the RfaF group of trans-
ferases. An alignment of the two encoded proteins, HptA and
HptB, showed only 21% identity. However, HptB has 53%
identity with the heptosyl-I-transferase WaaC (RfaC), which
adds heptose to the Kdo-Kdo LPS acceptor molecule in Sal-
monella enterica serovar Typhimurium (27), while HptA has
72% identity to OpsX, a heptosyl-I-transferase in Haemophilus
influenzae which adds the first heptose to a singly phosphory-
lated Kdo acceptor molecule (11).
The protein encoded by the P. multocida VP161 gene kdkA
(designated PM1303 on the Pm70 genome) shares 58% iden-
tity to the known Kdo kinase KdkA in H. influenzae (34) and
belongs to the family of LPS kinases (pfam06293). It is there-
fore predicted to encode the kinase required for the addition
of the phosphate group to the Kdo residue.
Sequencing of the VP161 genome within the regions that
encoded HptA, HptB, and KdkA revealed that all genes were
very highly conserved and that the genetic organization was
identical to the corresponding regions in the annotated Pm70
genome. Each of the candidate genes identified in VP161 was
mutated by insertional inactivation, and each mutant was com-
plemented with the full-length gene cloned into the P. multo-
cida expression vector pAL99 (Table 1).
Structural analysis of the mutants expressing modified LPS
forms. CE-MS analyses of the LPS-OH isolated from the mu-
tant strains are summarized in Table 3. The hptA mutant
(AL836) produced a fully extended glycoform B (consisting of
lipid A-Kdo1-Kdo2), but no fully extended glycoform A was
expressed. Additionally, doubly and triply charged ions at m/z
678.4 and 451.6, respectively, indicated an accumulation of
lipid A-Kdo1-P truncated LPS (Fig. 2A). In contrast, analysis
of the LPS from the hptB mutant (AL690) showed a fully
extended glycoform A, and an accumulation of the lipid
A-Kdo1-Kdo2 species was observed by virtue of the doubly and
triply charged ions at m/z 757.2 and 504.4, respectively (Fig.
2B). The accumulation of the alternative truncated LPS in
each of the mutants clearly suggests that HptA cannot utilize
FIG. 2. Negative-ion CE-ES-MS of the LPS-OH from AL836
(hptA) (A), AL690 (hptB) (B), and AL721 (kdkA) (C), showing the
relative abundances of truncated and full-length LPS. The inset within
each panel shows a carbohydrate silver stain of proteinase K-treated
whole-cell lysates with parent AL435 (left lane) and the relevant LPS
mutant (right lane).
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lipid A-Kdo1-Kdo2 and that HptB is unable to utilize lipid
A-Kdo1-P as an acceptor molecule. The Kdo kinase (KdkA)
mutant (AL721) produced a fully extended glycoform B but no
glycoform A and no accumulation of truncated LPS (Fig. 2C).
These data indicate that an unphosphorylated Kdo on the
acceptor molecule is freely available for the addition of a
second Kdo residue allowing glycoform B to be produced.
When complemented in trans with the appropriate genes, all
mutant strains produced both wild-type glycoforms (Table 3).
Virulence of the mutants expressing modified LPS forms.
To determine if any of the mutants were capable of causing
fowl cholera, virulence assays were performed. All birds except
those injected with the hptA mutant succumbed to fowl cholera
infection and were euthanatized (Table 4). Blood samples
taken from all birds were plated onto BHI to determine levels
of bacteremia. Blood samples taken from birds injected with
VP161, AL435, AL690, and AL721 showed greater than 104
CFU/ml, but no bacteria were recovered from the blood of
birds injected with the hptA mutant (AL836). Similarly, muscle
was sampled at the site of injection from birds in all groups,
and all birds except those from the AL836 group were positive
for P. multocida.
The hptA gene is located upstream of PM1301, which en-
codes a putative ABC transporter. To rule out the involvement
of PM1301 in the observed phenotype, the mutant was com-
plemented in trans with an intact copy of hptA and tested by
competition assay. The complemented mutant (AL847) was
able to grow in vivo with an average rCI value of 0.73, whereas
neither the mutant with vector (AL846) nor the hptA mutant
(AL704) could grow (rCI 
 0.0). Therefore, HptA activity is
essential for P. multocida virulence.
Structural analysis of LPS expressed by P. multocida during
in vivo growth. Based on negative-ion CE-ES-MS data ob-
tained for the P. multocida strains VP161 (this study) and X73
(28), glycoform A is the dominant structure, comprising 70 to
80% of the total LPS produced by both strains. To determine
if both glycoforms observed from in vitro-grown P. multocida
were also expressed by the bacteria during growth in the host,
chickens were infected with P. multocida strain X73. This se-
rotype A:1 strain is closely related to VP161 and expresses very
similar LPS structures (28), but it has the unique ability to grow
to very high numbers (up to 5  1010 CFU/ml) in the blood of
chickens, thus allowing analytical quantities of LPS to be iso-
lated. Chickens were injected intramuscularly with P. multo-
cida and the infection allowed to proceed until the birds
showed late signs of fowl cholera infection. P. multocida was
harvested from the blood and LPS isolated from the bacteria.
Structural analysis of the LPS isolated from in vivo-grown
bacteria showed that the type and amount of each LPS glyco-
form were the same as those observed from LPS isolated from
in vitro-grown cells (data not shown) (28).
Sensitivity of LPS mutants to the antimicrobial peptide fow-
licidin-1. To determine if P. multocida LPS mutants were more
susceptible than the parent strain to chicken antimicrobial pep-
tides, we performed bactericidal assays with the peptide fowlici-
din-1 and compared the sensitivities of the parent strain AL435,
the heptosyltransferase mutants (AL690 and AL836), and the
Kdo kinase mutant (AL721) (Fig. 3). Both of the heptosyltrans-
ferase mutants were more sensitive to the effects of fowlicidin-1
than either parent strain or the Kdo kinase mutant. However,
TABLE 4. Virulence of wild-type (VP161) and parent (AL435)
strains and LPS mutants as determined by intramuscular
challenge of 12-week-old Hy-Line Brown chickens
Strain (relevant
genotype)
Dose
(CFU)
Survivala
No. surviving/total Time (h)
VP161 1.3  103 0/9 14–19
AL435 1.7  103 0/4 14–19
AL836 (hptA) 7  102 9/9 NAb
AL690 (hptB) 6  102 0/9 16–19
AL721 (kdkA) 1  103 0/4 14–20
a All birds that reached an agreed stage of the infection were euthanatized in
accordance with animal ethics requirements.
b NA, not applicable.
FIG. 3. Sensitivities of the P. multocida parent strain (AL435) and of LPS mutants AL836 (hptA), AL690 (hptB), and AL721 (kdkA) to the
action of fowlicidin-1. Bacterial survival was determined by direct colony counts after incubation with various concentrations of synthetic
fowlicidin-1 for 1 h at 37°C. Numbers are the mean percent survival for three replicates, and error bars are 1 standard deviation.
3890 HARPER ET AL. INFECT. IMMUN.
 o
n
 Septem
ber 15, 2016 by University of Queensland Library
http://iai.asm
.org/
D
ow
nloaded from
 
there was no significant difference in sensitivity between the two
heptosyltransferase mutants, AL690 and AL836.
DISCUSSION
The P. multocida fowl cholera-causing isolates VP161 and
X73, when propagated in vitro in BHI, express two LPS gly-
coforms containing either a single Kdo residue, which we have
designated glycoform A, or two Kdo residues, which we have
designated glycoform B (28, 29). The Kdo1 residue in glyco-
form A has a phosphate residue at the 4 position to which, in
the majority of cases, a PEtn residue is attached. Glycoform A
also has a glucose residue attached to the 6 position of the first
heptose moiety (Fig. 1). In contrast, glycoform B contains two
Kdo residues that lack the phosphate or PEtn residues and
does not have the second glucose residue (Fig. 1). The expres-
sion of two very different Kdo region structures while the same
oligosaccharide extension is retained is unusual. Other bacteria
that express LPS lacking O polysaccharide include Campy-
lobacter jejuni, H. influenzae, Neisseria gonorrhoeae, and Neis-
seria meningitidis. Typically, changes in structure occur in the
outer core oligosaccharide extension and branch chains which
lead to diversity in the LPS structure (reviewed in reference
24). Changes in LPS structure in these bacteria are often the
result of phase variation caused by slipped-strand mispairing of
homopolymeric tracts or multiple tandem repeats in DNA that
results in the switching on or off of key LPS genes (16, 33).
However, we have examined the annotated Pm70 genome and
the sequenced LPS regions from a number of other P. multo-
cida strains and have found no evidence of any genes that are
subject to this type of phase variation.
Bioinformatic analysis of the genome of P. multocida strain
Pm70 revealed two encoded proteins with similarity to known
heptosyl-1-transferases. One of these, HptB (Pm1843 in
Pm70), shares identity with WaaC, a transferase required for
the addition of the first heptose residue to the lipid A-Kdo-
Kdo acceptor molecule in bacteria belonging to the Enterobac-
teriaceae family (24, 27). The second transferase, HptA (anno-
tated in Pm70 as OpsX), is similar to OpsX in H. influenzae, a
novel type of heptosyltransferase that transfers the first hep-
tose residue onto a Kdo-lipid A but only if the Kdo residue is
phosphorylated (11). A search of all available bacterial ge-
nomes at NCBI revealed that only Mannheimia haemolytica,
Mannheimia succiniciproducens, and Actinobacillus pleuropneu-
moniae harbor the genes for both types of heptosyltransferase
I; these species are also members of the Pasteurellaceae family.
Of these, only M. haemolytica has been shown to express more
than one inner core LPS glycoform (19). The LPS structures of
A. pleuropneumoniae strains examined so far produce only one
inner core glycoform containing a single Kdo residue (31),
while the composition of LPS expressed by M. succiniciprodu-
cens is unknown.
In addition to the identification of HptA and HptB as the
predicted heptosyl-1-transferases, the gene PM1303 was also
identified as encoding the putative Kdo kinase (KdkA) re-
quired for phosphorylation of the Kdo1 residue in P. multocida
VP161 (Fig. 1). To confirm the roles of HptA, HptB, and
KdkA in LPS biosynthesis, we constructed mutants with mu-
tations in each of the identified genes in strain VP161. Inacti-
vation of hptA produced a mutant strain (AL836) that ex-
pressed glycoform B, but approximately 37% of the LPS
consisted of the highly truncated species lipid A-Kdo1-P (Table
3; Fig. 2A). This is consistent with hptA encoding the trans-
ferase required for the addition of the first heptose residue to
the lipid A-Kdo1-P core. The function of HptA was confirmed
with structural data on the complemented mutant, AL847,
which showed restoration of full-length LPS for both glyco-
forms.
Inactivation of hptB produced a mutant strain (AL690) that
expressed both full-length glycoform A and a truncated LPS
species, estimated at 15% of the total product, consisting of
lipid A-Kdo1-Kdo2 (Table 3; Fig. 2B). Complementation of
this mutant with a functional hptB gene restored expression
of the entire glycoform B. These data support the hypothesis
that hptB encodes the heptosyltransferase required for the
addition of the first heptose to the lipid A-Kdo1-Kdo2 core.
Thus, HptB and HptA are both heptosyl-1-transferases, but
each transferase exclusively recognizes different acceptor mol-
ecules, with HptA transferring heptose to lipid A-Kdo1-P and
HptB transferring heptose to lipid A-Kdo1-Kdo2. Virulence
data showed that the hptB mutant, AL690, was still capable of
causing lethal infection in chickens (Table 4). However, the
hptA mutant, AL836, was fully attenuated. These data sug-
gested that either glycoform A was critical for growth in vivo or
AL836 was unable to survive in the host because of the amount
of truncated LPS present on the surface; MS analysis indicated
that the fully attenuated hptA mutant expressed more than
twice the amount of truncated LPS as the virulent hptB mutant
did (Fig. 2; Table 3).
To determine if expression of only glycoform B was sufficient
for P. multocida growth in vivo, we constructed a Kdo kinase
(kdkA) mutant. This kinase was predicted to add the phos-
phate residue to the first Kdo residue and thus should be
essential for the synthesis of glycoform A. Structural analysis of
the LPS expressed by the Kdo kinase mutant (AL721) indi-
cated that it produced only glycoform B and not glycoform A,
confirming the function of KdkA as the Kdo kinase (Table 3;
Fig. 2C). Moreover, the Kdo kinase mutant expressed no trun-
cated LPS, confirming that the lipid A-Kdo1 structure acts as
an acceptor molecule both for the addition of a second Kdo
molecule and for phosphorylation by KdkA.
We predict that P. multocida, like E. coli, expresses a bifunc-
tional Kdo transferase (KdtA) that can attach both the first
and second Kdo residues to lipid A (3). Because of the pre-
dicted bifunctional nature of KdtA, we hypothesize that in
wild-type P. multocida the Kdo kinase (KdkA) competes with
the Kdo transferase (KdtA) for access to the lipid A-Kdo1
acceptor molecule, and the predominance of glycoform A (70
to 80% of total LPS) suggests that phosphorylation of the first
Kdo residue (by KdkA) occurs at a higher rate than the addi-
tion of the second Kdo residue by KdtA. Once phosphorylated,
the lipid A-Kdo1 is not recognized by the Kdo transferase as an
acceptor molecule. However, in the kdkA mutant, which lacks
a functional Kdo kinase, the Kdo transferase has unhindered
access to the lipid A-Kdo1, allowing all of the substrate to be
converted to lipid A-Kdo1-Kdo2, the acceptor molecule recog-
nized by the heptosyltransferase HptB. In order to confirm the
function of KdtA in P. multocida, we attempted to construct a
mutant with an insertion in the kdtA gene, but were unsuccess-
ful. This is not surprising, as the lack of a functional Kdo
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transferase would most likely result in a nonviable mutant that
lacks any LPS on its surface (24).
Although both the hptA mutant (AL836) and the kdkA mu-
tant (AL721) expressed full-length LPS glycoform B, the kdkA
mutant was fully virulent while the hptA mutant was fully
attenuated (Table 4). The virulence data obtained for the kdkA
mutant indicate that P. multocida VP161 can grow in vivo while
expressing only glycoform B LPS. Therefore, the attenuation
observed in the hptA mutant is probably due to the expression
of a large amount of truncated LPS that makes the bacteria
more vulnerable to host defense mechanisms than strains ex-
pressing only full-length LPS.
Antimicrobial peptides are a critical component of the in-
nate immune systems of higher organisms (17) and are known
to interact with LPS. It has been demonstrated in other bac-
terial species that truncation or alteration of the LPS alters
resistance to antimicrobial peptide activity (20, 25). A number
of chicken antimicrobial peptides have been characterized, in-
cluding members of the -defensin (15) and cathelicidin (36)
families. In this study, the resistance of each of the P. multocida
LPS mutants to the cathelicidin fowlicidin-1 was determined.
We found that although the hptB mutant could cause disease
and the hptA mutant could not, bactericidal assays showed
both the heptosyltransferase mutants were more sensitive to
fowlicidin-1 than the parent strain AL435. Therefore, the pro-
found difference in the abilities of these mutants to cause
disease in the host does not correlate directly with sensitivity to
the lytic peptide fowlicidin-1. Other antimicrobial peptides, in
addition to the complement membrane attack complex and
Toll-like receptors on macrophages and heterophils, are also
likely to play a role in host defense. Moreover, the Kdo kinase
mutant (AL721) was only slightly sensitive to fowlicidin com-
pared to the parent strain (AL435) but was significantly more
resistant than the hptA mutant. These two mutants both ex-
press full-length glycoform B, but AL836 also expresses a large
amount of truncated LPS, indicating that susceptibility of the
LPS mutant strains to fowlicidin-1 is directly related to the
expression of truncated LPS.
It is interesting that P. multocida can cause disease in the
host with only the expression of glycoform B, yet both glyco-
forms are expressed simultaneously in vitro. To determine if
the expression of both glycoforms also occurred in vivo, we
isolated bacteria from the blood of chickens infected with P.
multocida strain X73 and analyzed the in vivo-expressed LPS
by MS. The ratio and type of LPS expressed at a late stage of
infection in chickens were very similar to those of LPS ex-
pressed in vitro. It is not clear whether P. multocida can cause
disease with expression of only glycoform A, as we have been
unable to construct a mutant that produced full-length glyco-
form A and no other LPS species. Such a mutant would require
the addition of only the first Kdo residue, and we predict that
the Kdo transferase, KdtA, is bifunctional, transferring both the
Kdo1 and Kdo2 molecules. Therefore, we have no mechanism
to prevent the addition of Kdo2 while allowing the transfer of
Kdo1. It is probable that neither glycoform A nor B is delete-
rious for the bacteria growing systemically within the host, as
both are clearly expressed in this niche in vivo, but perhaps the
expression and regulation of two different glycoforms allow
for P. multocida survival in different environments within
the host. We are currently investigating this possibility.
ACKNOWLEDGMENTS
We thank Marietta John for excellent technical assistance. We
also thank Perry Fleming for bacterial growth and Jacek Stupak for
CE-MS.
This work was funded in part by grants from the Australian Re-
search Council, Canberra, Australia, and the Australian Poultry Co-
operative Research Centre.
REFERENCES
1. Altschul, S. F., T. L. Madden, A. A. Schaffer, J. Zhang, Z. Zhang, W. Miller,
and D. J. Lipman. 1997. Gapped BLAST and PSI-Blast: a new generation of
protein database search programs. Nucleic Acids Res. 25:3389–3402.
2. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A.
Smith, and K. Struhl (ed.). 1995. Current protocols in molecular biology, vol.
1. John Wiley & Sons, Inc., New York, NY.
3. Belunis, C. J., and C. R. Raetz. 1992. Biosynthesis of endotoxins. Purification
and catalytic properties of 3-deoxy-D-manno-octulosonic acid transferase
from Escherichia coli. J. Biol. Chem. 267:9988–9997.
4. Birnboim, H. C., and J. Doly. 1979. A rapid alkaline extraction procedure for
screening recombinant plasmid DNA. Nucleic Acids Res. 7:1513–1523.
5. Boyce, J., R. Y. C. Lo, I Wilkie, and B. Adler. 2004. Pasteurella and Mann-
heimia, p. 385–396. In C. L. Gyles, C. O. Thoen, J. F. Prescott, and G. Songer
(ed.), Pathogenesis of bacterial infections of animals. Blackwell Publishing,
Oxford, United Kingdom.
6. Boyce, J. D., I. Wilkie, M. Harper, M. L. Paustian, V. Kapur, and B. Adler.
2002. Genomic scale analysis of Pasteurella multocida gene expression during
growth within the natural chicken host. Infect. Immun. 70:6871–6879.
7. Cardenas, M., A. R. Fernandez de Henestrosa, S. Campoy, A. M. Perez de
Rozas, J. Barbe, I. Badiola, and M. Llagostera. 2001. Virulence of Pasteu-
rella multocida recA mutants. Vet. Microbiol. 80:53–61.
8. Coutinho, P. M., and B. Henrissat. 1999. Carbohydrate-active enzymes: an
integrated database approach., p. 3–12. In H. G. Gilbert, G. Davies, B.
Henrissat and B. Svensson (ed.), Recent advances in carbohydrate bioengi-
neering. The Royal Society of Chemistry, Cambridge, United Kingdom.
9. Cox, A. D., H. Masoud, P. Thibault, J. R. Brisson, M. van der Zwan, M. B.
Perry, and J. C. Richards. 2001. Structural analysis of the lipopolysaccharide
from the nontypable Haemophilus influenzae strain SB 33. Eur. J. Biochem.
268:5278–5286.
10. Gamian, A., M. Beurret, F. Michon, J. R. Brisson, and H. J. Jennings. 1992.
Structure of the L2 lipopolysaccharide core oligosaccharides of Neisseria
meningitidis. J. Biol. Chem. 267:922–925.
11. Gronow, S., W. Brabetz, B. Lindner, and H. Brade. 2005. OpsX from Hae-
mophilus influenzae represents a novel type of heptosyltransferase I in lipo-
polysaccharide biosynthesis. J. Bacteriol. 187:6242–6247.
12. Harper, M., J. D. Boyce, I. W. Wilkie, and B. Adler. 2003. Signature-tagged
mutagenesis of Pasteurella multocida identifies mutants displaying differen-
tial virulence characteristics in mice and chickens. Infect. Immun. 71:5440–
5446.
13. Harper, M., A. D. Cox, F. St Michael, I. W. Wilkie, J. D. Boyce, and B. Adler.
2004. A heptosyltransferase mutant of Pasteurella multocida produces a trun-
cated lipopolysaccharide structure and is attenuated in virulence. Infect.
Immun. 72:3436–3443.
14. Heddleston, K. L., and P. A. Rebers. 1972. Fowl cholera. Cross immunity
induced in turkeys with formalin-killed in-vivo-propagated Pasteurella mul-
tocida. Avian Dis. 16:578–586.
15. Higgs, R., D. J. Lynn, S. Gaines, J. McMahon, J. Tierney, T. James, A. T.
Lloyd, G. Mulcahy, and C. O’Farrelly. 2005. The synthetic form of a novel
chicken beta-defensin identified in silico is predominantly active against
intestinal pathogens. Immunogenetics 57:90–98.
16. Jennings, M. P., D. W. Hood, I. R. Peak, M. Virji, and E. R. Moxon. 1995.
Molecular analysis of a locus for the biosynthesis and phase-variable expres-
sion of the lacto-N-neotetraose terminal lipopolysaccharide structure in
Neisseria meningitidis. Mol. Microbiol. 18:729–740.
17. Jenssen, H., P. Hamill, and R. E. Hancock. 2006. Peptide antimicrobial
agents. Clin. Microbiol. Rev. 19:491–511.
18. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of
the head of bacteriophage T4. Nature 227:680–685.
19. Logan, S. M., W. Chen, A. Aubry, M. A. Gidney, S. Lacelle, F. St. Michael,
R. Kuolee, M. Higgins, S. Neufeld, and A. D. Cox. 2006. Production of a
D-glycero-D-manno-heptosyltransferase mutant of Mannheimia haemolytica
displaying a veterinary pathogen specific conserved LPS structure; develop-
ment and functionality of antibodies to this LPS structure. Vet. Microbiol.
116:175–186.
20. Loutet, S. A., R. S. Flannagan, C. Kooi, P. A. Sokol, and M. A. Valvano. 2006.
A complete lipopolysaccharide inner core oligosaccharide is required for
resistance of Burkholderia cenocepacia to antimicrobial peptides and bacte-
rial survival in vivo. J. Bacteriol. 188:2073–2080.
21. Marchler-Bauer, A., and S. H. Bryant. 2004. CD-Search: protein domain
annotations on the fly. Nucleic Acids Res. 32:W327–331.
22. Michon, F., M. Beurret, A. Gamian, J. R. Brisson, and H. J. Jennings. 1990.
3892 HARPER ET AL. INFECT. IMMUN.
 o
n
 Septem
ber 15, 2016 by University of Queensland Library
http://iai.asm
.org/
D
ow
nloaded from
 
Structure of the L5 lipopolysaccharide core oligosaccharides of Neisseria
meningitidis. J. Biol. Chem. 265:7243–7247.
23. Miller, V. L., and J. J. Mekalanos. 1988. A novel suicide vector and its use
in construction of insertion mutations: osmoregulation of outer membrane
proteins and virulence determinants in Vibrio cholerae requires toxR. J.
Bacteriol. 170:2575–2583.
24. Raetz, C. R., and C. Whitfield. 2002. Lipopolysaccharide endotoxins. Annu.
Rev. Biochem. 71:635–700.
25. Ramjeet, M., V. Deslandes, F. St Michael, A. D. Cox, M. Kobisch, M.
Gottschalk, and M. Jacques. 2005. Truncation of the lipopolysaccharide
outer core affects susceptibility to antimicrobial peptides and virulence of
Actinobacillus pleuropneumoniae serotype 1. J. Biol. Chem. 280:39104–39114.
26. Schweda, E. K., A. C. Sundstrom, L. M. Eriksson, J. A. Jonasson, and A. A.
Lindberg. 1994. Structural studies of the cell envelope lipopolysaccharides
from Haemophilus ducreyi strains ITM 2665 and ITM 4747. J. Biol. Chem.
269:12040–12048.
27. Sirisena, D. M., K. A. Brozek, P. R. MacLachlan, K. E. Sanderson, and C. R.
Raetz. 1992. The rfaC gene of Salmonella typhimurium. Cloning, sequencing,
and enzymatic function in heptose transfer to lipopolysaccharide. J. Biol.
Chem. 267:18874–18884.
28. St. Michael, F., J. Li, and A. D. Cox. 2005. Structural analysis of the core
oligosaccharide from Pasteurella multocida strain X73. Carbohydr. Res. 340:
1253–1257.
29. St. Michael, F., J. Li, E. Vinogradov, S. Larocque, M. Harper, and A. D. Cox.
2005. Structural analysis of the lipopolysaccharide of Pasteurella multocida
strain VP161: identification of both Kdo-P and Kdo-Kdo species in the
lipopolysaccharide. Carbohydr. Res. 340:59–68.
30. St. Michael, F., E. Vinogradov, J. Li, and A. D. Cox. 2005. Structural analysis
of the lipopolysaccharide from Pasteurella multocida genome strain Pm70
and identification of the putative lipopolysaccharide glycosyltransferases.
Glycobiology 15:323–333.
31. St. Michael, F. S., J. R. Brisson, S. Larocque, M. Monteiro, J. Li, M.
Jacques, M. B. Perry, and A. D. Cox. 2004. Structural analysis of the lipo-
polysaccharide derived core oligosaccharides of Actinobacillus pleuropneu-
moniae serotypes 1, 2, 5a and the genome strain 5b. Carbohydr. Res. 339:
1973–1984.
32. Tsai, C. M., and C. E. Frasch. 1982. A sensitive silver stain for detecting
lipopolysaccharides in polyacrylamide gels. Anal. Biochem. 119:115–119.
33. Weiser, J. N., J. M. Love, and E. R. Moxon. 1989. The molecular mechanism
of phase variation of H. influenzae lipopolysaccharide. Cell 59:657–665.
34. White, K. A., S. Lin, R. J. Cotter, and C. R. Raetz. 1999. A Haemophilus
influenzae gene that encodes a membrane bound 3-deoxy-D-manno-octu-
losonic acid (Kdo) kinase. Possible involvement of Kdo phosphorylation in
bacterial virulence. J. Biol. Chem. 274:31391–31400.
35. Wilkie, I. W., S. E. Grimes, D. O’Boyle, and A. J. Frost. 2000. The virulence
and protective efficacy for chickens of Pasteurella multocida administered by
different routes. Vet. Microbiol. 72:57–68.
36. Xiao, Y., Y. Cai, Y. R. Bommineni, S. C. Fernando, O. Prakash, S. E.
Gilliland, and G. Zhang. 2006. Identification and functional characterization
of three chicken cathelicidins with potent antimicrobial activity. J. Biol.
Chem. 281:2858–2867.
Editor: V. J. DiRita
VOL. 75, 2007 THE NOVEL INNER CORE OF P. MULTOCIDA LPS AND VIRULENCE 3893
 o
n
 Septem
ber 15, 2016 by University of Queensland Library
http://iai.asm
.org/
D
ow
nloaded from
 
